Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) FCF Margin: 2019-2025

Historic FCF Margin for Eton Pharmaceuticals (ETON) over the last 6 years, with Sep 2025 value amounting to 52.28%.

  • Eton Pharmaceuticals' FCF Margin rose 2369.00% to 52.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 38.33%, marking a year-over-year increase of 3465.00%. This contributed to the annual value of 2.42% for FY2024, which is 1912.00% down from last year.
  • Eton Pharmaceuticals' FCF Margin amounted to 52.28% in Q3 2025, which was up 24.34% from 42.05% recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' FCF Margin registered a high of 117.02% during Q1 2025, and its lowest value of -380.90% during Q3 2021.
  • Over the past 3 years, Eton Pharmaceuticals' median FCF Margin value was 13.83% (recorded in 2024), while the average stood at 23.60%.
  • Examining YoY changes over the last 5 years, Eton Pharmaceuticals' FCF Margin showed a top increase of 1,425,297bps in 2021 and a maximum decrease of 24,095,071bps in 2021.
  • Over the past 5 years, Eton Pharmaceuticals' FCF Margin (Quarterly) stood at -84.05% in 2021, then spiked by 11,733bps to 33.28% in 2022, then plummeted by 3,198bps to 1.30% in 2023, then plummeted by 797bps to -6.67% in 2024, then skyrocketed by 2,369bps to 52.28% in 2025.
  • Its FCF Margin stands at 52.28% for Q3 2025, versus 42.05% for Q2 2025 and 117.02% for Q1 2025.